Ordinary Adjustment | Solactive China Biotech Index | Effective Date 14th July 2025
Solactive China Biotech Index:
In the ordinary adjustment, the following composition will be implemented effective open 14th July 2025:
| 3SBIO INC |
| AKESO INC |
| BEIJING TIANTAN BIOLOGICAL-A |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD |
| BEONE MEDICINES LTD-ADR |
| CHINA MEDICAL SYSTEM HOLDINGS LTD |
| GAN & LEE PHARMACEUTICALS -A |
| GENSCRIPT BIOTECH CORP |
| HANGZHOU TIGERMED CONSULTI-A |
| HANSOH PHARMACEUTICAL GROUP CO |
| HEBEI CHANGSHAN BIOCHEMICA-A |
| HUALAN BIOLOGICAL ENGINEER-A |
| HUBEI JUMPCAN PHARMACEUT-A |
| INNOVENT BIOLOGICS INC |
| JIANGSU HENGRUI MEDICINE CO LTD CLASS A |
| LIVZON PHARMACEUTICAL GROU-A |
| MGI TECH CO LTD |
| PHARMARON BEIJING CO LTD-A |
| REMEGEN CO LTD-A |
| SHANGHAI ALLIST PHARMACEUTICALS CO LTD |
| SHANGHAI JUNSHI BIOSCIENCE |
| SHANGHAI RAAS BLOOD PRODUC-A |
| SICHUAN BIOKIN PHARMACEUTICAL CO LTD |
| SINO BIOPHARMACEUTICAL LTD ORD |
| SKB BIO-B ORD H |
| SUNSHINE GUOJIAN PHARMACEUTICAL SHANGHAI CO LTD |
| WUXI APPTEC CO LTD-A |
| WUXI BIOLOGICS CAYMAN INC |
| XIAMEN AMOYTOP BIOTECH CO -A |
| ZAI LAB LTD |